Trademark: 87169143
Status Date
Tuesday, December 5, 2017
Registration Number
5351627
Registration Date
Tuesday, December 5, 2017
Filing Date
Tuesday, September 13, 2016
Published for Opposition
Tuesday, January 31, 2017
42 Pharmaceutical products development of new small molecules aimed at degrading disease-causing cellular proteins for treatment in the field of oncology, immunology, inflammatory diseases, and central nervous system disorders
Dec 4, 2023
Teas Section 8 & 15 Received
Dec 5, 2022
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Jul 3, 2019
Automatic Update Of Assignment Of Ownership
Oct 9, 2018
Attorney/Dom.Rep.Revoked And/Or Appointed
Oct 9, 2018
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Dec 5, 2017
Registered-Principal Register
Oct 28, 2017
Notice Of Acceptance Of Statement Of Use E-Mailed
Oct 27, 2017
Allowed Principal Register - Sou Accepted
Sep 28, 2017
Notice Of Approval Of Extension Request E-Mailed
Sep 27, 2017
Statement Of Use Processing Complete
Sep 15, 2017
Use Amendment Filed
Sep 27, 2017
Sou Extension 1 Granted
Sep 15, 2017
Sou Extension 1 Filed
Sep 26, 2017
Case Assigned To Intent To Use Paralegal
Sep 15, 2017
Sou Teas Extension Received
Sep 15, 2017
Teas Statement Of Use Received
Mar 28, 2017
Noa E-Mailed - Sou Required From Applicant
Jan 31, 2017
Official Gazette Publication Confirmation E-Mailed
Jan 31, 2017
Published For Opposition
Jan 11, 2017
Notification Of Notice Of Publication E-Mailed
Dec 23, 2016
Approved For Pub - Principal Register
Dec 19, 2016
Assigned To Examiner
Sep 16, 2016
New Application Office Supplied Data Entered
Sep 16, 2016
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
